aInstitute of Microbiology and Section of Infectious Diseases, University Hospital, Lausanne
bDivision of Clinical Pharmacology, University Hospital, Lausanne
cDivision of Infectious Diseases, University Hospital, Bern
dData Center Swiss HIV Cohort Study, Lausanne, Switzerland
Sponsorship: Support for this work was provided by the Swiss National Science Foundation (grant 3345C0-100935/1), by the Swiss HIV Cohort Study (Swiss National Science Foundation, grant 3345-062041), and by the Santos Suarez Foundation. MR is supported by an award from the Fondo de Investigacion Sanitaria, Spain (grant BF03/0005).
Correspondence and requests for reprints to Dr Amalio Telenti, Institute of Microbiology, Bugnon 48, CHUV, 1011 Lausanne
E-mail: [email protected]
Received 19 July 2004 Accepted 12 October 2004
*Contributed equally to the work.
§The members of the Swiss HIV Cohort Study are M. Battegay (Chairman of the Scientific Board), M.-C. Bernard, E. Bernasconi, H. Bucher, Ph. Bürgisser, M. Egger, P. Erb, W. Fierz, M. Flepp (Chairman of the Clinical and Laboratory Committee), P. Francioli (President of the SHCS, Centre Hospitalier Universitaire Vaudois, CH-1011-Lausanne), H.J. Furrer, M. Gorgievski, H. Günthard, P. Grob, B. Hirschel, C. Kind, Th. Klimkait, B. Ledergerber, U. Lauper, M. Opravil, F. Paccaud, G. Pantaleo, L. Perrin, J.-C. Piffaretti, M. Rickenbach (Head of Data Center), C. Rudin (Chairman of the Mother & Child Substudy), J. Schupbach, A. Telenti, P. Vernazza, Th. Wagels, R. Weber.
